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Immunology, RWTH University of Aachen, Aachen, GermanyA key feature of glomerular diseases such as crescentic
glomerulonephritis and focal segmental glomerulosclerosis
is the activation, migration and proliferation of parietal
epithelial cells. CD44-positive activated parietal epithelial
cells have been identified in proliferative cellular lesions in
glomerular disease. However, it remains unknown whether
CD44-positive parietal epithelial cells contribute to the
pathogenesis of scarring glomerular diseases. Here, we
evaluated this in experimental crescentic
glomerulonephritis and the transgenic anti-Thy1.1 model
for collapsing focal segmental glomerulosclerosis in CD44-
deficient (cd44-/-) and wild type mice. For both models
albuminuria was significantly lower in cd44-/- compared to
wild type mice. The number of glomerular Ki67-positive
proliferating cells was significantly reduced in cd44-/-
compared to wild type mice, which was associated with a
reduced number of glomerular lesions in crescentic
glomerulonephritis. In collapsing focal segmental
glomerulosclerosis, the extracapillary proliferative cellular
lesions were smaller in cd44-/- mice, but the number of
glomerular lesions was not different compared to wild type
mice. For crescentic glomerulonephritis the influx of
granulocytes and macrophages into the glomerulus was
similar. In vitro, the growth of CD44-deficient murine
parietal epithelial cells was reduced compared to wild type
parietal epithelial cells, and human parietal epithelial cell
migration could be inhibited using antibodies directed
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P arietal epithelial cells (PECs) line the Bowman capsuleof a healthy glomerulus. Like podocytes, PECs have thesame embryonic origin.1,2 Unlike podocytes, PECs
retain the ability to proliferate, which occurs under pathologic
conditions.3,4 In adult kidney, various subpopulations of
PECs have been described, such as parietal podocytes,5–7
adult parietal epithelial multipotent progenitors,8,9 and
activated PECs,4,10,11 with some variation among species.
Activated PECs are known mainly for their involvement in
the development of hyperplastic lesions in focal and
segmental glomerulosclerosis (FSGS) and crescentic
glomerulonephritis.10,12
Extracapillary proliferative lesions or crescents are the
hallmark of both inflammatory and noninflammatory
glomerular diseases. In fact, lesion formation or glomerular
scarring is responsible for the irreversible loss of renal func-
tion in most glomerular diseases. Evidence indicates that the
extracapillary proliferative cellular lesions in (experimental)
crescentic glomerulonephritis and collapsing focal and
segmental glomerulosclerosis (FSGS) are composed mainly of
activated PECs.4,10 In experimental collapsing FSGS, induced
damage to podocytes triggers the activation of PECs followed
by the formation of adhesions and invasion by PECs of the
glomerular tuft. The migrating and proliferating activated
PECs deposit extracellular matrix material, which accumu-
lates over time, resulting in segmental, and ultimately global,
scarring of the glomerular tuft.10,12 In experimental crescentic
glomerulonephritis, anti-glomerular basement membrane1
bas i c re sea r ch J Eymael et al.: CD44 drives PECs in crescentic glomerulonephritis and FSGS(anti-GBM) antibodies, eventually in conjunction with
toll-like-receptor (TLR) ligands, lead to activation of the
complement system and glomerular influx of inflammatory
cells, such as granulocytes and macrophages.13–15 Simulta-
neously, PECs, and to a lesser extent podocytes, are activated,
thereby generating proliferative cellular lesions and the typical
crescents, which may block the tubular outlet and urinary
flow.4
The proliferative cells within sclerotic lesions have been
identified as activated PECs in human biopsies of a range of
glomerular diseases as well.11,16–21 Based on the aforemen-
tioned animal and human studies, activation of PECs has
been proposed as a common mechanism in crescentic
glomerulonephritis and primary and secondary FSGS.12,22
Activated PECs can be identified by an acquired expression
of cluster of differentiation 44 (CD44), which is a cell surface
glycoprotein that plays a key role in various cellular processes,
such as cell differentiation, cell migration, cell-matrix bind-
ing, leukocyte trafficking, and scar formation.23 Normally,
CD44 is not expressed in a healthy glomerulus, but CD44
expression by proliferating PECs is higher in crescents and
lesions in the presence of crescentic glomerulonephritis and
FSGS.11,24–26 The specific pattern of CD44 expression on
activated PECs may suggest that CD44 expression by PECs
contributes to the pathogenesis of scarring glomerular
diseases. However, whether the acquired CD44 expression by
activated PECs is a cause or consequence of glomerularFigure 1 | Confirmation of CD44 deficiency in cd44–/– mice. To confirm
cryosections were stained with anti-CD44 antibody 14 days after nephro
following: wild-type (WT) mouse injected with saline only (a); WT mous
and secondary antibody control (d). Only in the WT mouse injected wit
Bar ¼ 100 mm. Immunostaining for CD44 on a kidney section stained wit
(f), respectively. Only in the WT mouse CD44 immunostaining was dete
glomerular area (asterisks). Bar ¼ 50 mm. To optimize viewing of this im
international.org.
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scarring is not clear. In the current study, we evaluated the
role of CD44 in experimental crescentic glomerulonephritis
and FSGS, which revealed that CD44 is required for the
pathogenesis of these scarring glomerular diseases.
RESULTS
CD44 deficiency reduces glomerular fibrinogen deposition
and albuminuria in crescentic glomerulonephritis
To evaluate the role of CD44 in scarring glomerular diseases,
we induced crescentic glomerulonephritis in wild-type (WT)
and CD44-deficient (cd44–/–) mice and analyzed these mice
at day 14. WT mice injected with saline showed no renal
CD44 expression (Figure 1a), whereas nephrotoxic serum
(NTS)–injected WT mice acquired glomerular, peri-
glomerular, and tubular CD44 expression (Figure 1b and e).
As expected, NTS-injected cd44–/– mice displayed no renal
CD44 expression (Figure 1c, d, and f). To assess whether
CD44 deficiency results in a kidney phenotype, we examined
the histology and presence of granulocytes, macrophages, B
cells, and T cells in normal, i.e., non-treated, WT and cd44–/–
mice. Both types of mice had a normal renal histology
(Supplementary Figure S1), and no differences were observed
in the number of immune cells within the kidney (data not
shown).
To exclude the possibility that CD44 deficiency affects the
binding of the sheep anti-GBM serum, we stained for sheep Ig
and found a similar appearance for WT and cd44–/– micecluster of differentiation 44 (CD44) deficiency in cd44–/– mice, renal
toxic serum (NTS) injection, versus controls. Shown are the
e injected with NTS (b); cd44–/– mouse after NTS injection (c);
h NTS was a de novo expression of CD44 detected (b, arrowhead).
h periodic acid–Schiff of an NTS-injected WT (e) and a cd44–/– mouse
cted in the epithelial cells of affected glomeruli and in the peri-
age, please see the online version of this article at www.kidney-
Kidney International (2018) -, -–-
Figure 2 | Reduced fibrinogen deposition in cd44–/– mice. Effect of cluster of differentiation 44 (CD44) deficiency on nephrotoxic serum
(NTS) antibody binding and complement C3c and fibrinogen deposition in glomeruli. Immunostaining using anti-sheep Alexa 594 conjugated
secondary antibody 14 days after injection to compare sheep IgG binding to the glomerular basement membrane of wild-type (WT) (a) and
cd44–/– mice (b). Complement C3c deposition in the glomeruli of NTS-injected WT (c) and cd44–/– mice (d). Fibrinogen deposition in the
glomeruli of NTS-injected WT (e) and cd44–/– mice (f). Bar ¼ 100 mm. To optimize viewing of this image, please see the online version of this
article at www.kidney-international.org.
J Eymael et al.: CD44 drives PECs in crescentic glomerulonephritis and FSGS bas i c re sea r ch(Figure 2a and b). In accordance with equal glomerular Ig
binding, glomerular complement factor C3c deposition was
found to be similar in WT and cd44–/– mice (Figure 2c and
d). Glomerular fibrinogen deposition, an important mediator
in crescentic glomerulonephritis,27 was markedly reduced in
cd44–/– mice, compared with WT mice (Figure 2e and f).
The urinary albumin:creatinine ratio of cd44–/– mice was
4-fold lower, compared with that in WT mice (Figure 3a).
Renal function did not differ between NTS-injected WT and
cd44–/– mice, which had respective blood urea nitrogenKidney International (2018) -, -–-values of 15.1  1.2 versus 17.1  1.9 mmol/l, compared with
12.1  0.6 mmol/l for saline-injected controls.
CD44 deficiency reduces glomerular injury and glomerular
cell proliferation in crescentic glomerulonephritis
Analysis of renal histology showed about 2-fold less affected
glomeruli (w20% vs. w50%) in NTS-injected cd44–/– mice,
compared with WT mice (Figure 3b). In particular, cd44–/–
mice (Figure 3d and f) displayed less crescent formation
compared with WT mice (Figure 3c and e).3
Figure 3 | Reduced proteinuria and crescent formation in cluster of differentiation 44–deficient (cd44–/–) mice. Proteinuria expressed as
mg albumin/mg creatinine ratio in wild-type (WT) and cd44–/– mice on day 14 after nephrotoxic serum (NTS) injection (a). The formation of
crescents or hyalinosis in the glomeruli was determined by analysis of at least 50 glomeruli per mouse and expressed as the percentage
of affected glomeruli in WT and cd44–/– mice on day 14 after NTS injection (b). Data are given as mean  SEM (n ¼ 5). Mann Whitney U test
(2-tailed); **P < 0.01. Representative images of sections stained with periodic acid–Schiff of WT control mice (c,e) and cd44–/– mice (d,f).
Bar ¼ 100 mm (c,d) and 50 mm (e,f). Hyperplasia or multilayered accumulation of cells forming (pseudo)-crescents (c,d,e, arrows) and deposition
of extracellular matrix between the cellular layers (e, open arrow) are depicted. To optimize viewing of this image, please see the online version
of this article at www.kidney-international.org.
bas i c re sea r ch J Eymael et al.: CD44 drives PECs in crescentic glomerulonephritis and FSGSGiven that we observed hyperplasia resulting in multilayers
of cells in Bowman space and an occasional mitotic body,
indicating cell proliferation, we next analyzed glomerular cell
proliferation, which may contribute to the formation of
crescents. A count of the number of Ki67-positive cells in
both the glomerular tuft and Bowman space showed, for both
compartments, about 2-fold fewer proliferating cells in4
cd44–/– mice, compared with WT mice, whereas the differ-
ences in Bowman space seemed more pronounced
(Figure 4a–d).
Fewer PECs in crescentic lesions in cd44–/– mice
To examine the presence of activated PECs, we stained for PEC
markers SSeCKS and claudin-1, and for CD44. As illustrated inKidney International (2018) -, -–-
Figure 4 | Reduced proliferation of glomerular cells in cluster of differentiation 44–deficient (cd44–/–) mice. The number of Ki67-positive
cells located in the glomerular tuft (a) and Bowman space (b) was counted in 50 glomeruli of wild-type (WT) and cd44–/– mice on 3,3’-dia-
minobenzidine–stained formalin-fixed paraffin sections (c,d). Data are given as mean  SEM for WT (n ¼ 5) and cd44–/– (n ¼ 5) mice. Mann-
Whitney U test (2-tailed); *P < 0.05. Representative image showing Ki67 positive cells 14 days after nephrotoxic serum injection in WT (c) and
cd44–/– mice (d). Cells positive for Ki67 were detected in the glomerular tuft (black arrowheads), Bowman space (arrows), tubular epithelium
(white arrows), and tubulointerstitium (white arrowhead) of WT and cd44–/– mice. Bar ¼ 50 mm. To optimize viewing of this image, please see
the online version of this article at www.kidney-international.org.
J Eymael et al.: CD44 drives PECs in crescentic glomerulonephritis and FSGS bas i c re sea r chFigure 5a, NTS-injected WT mice consistently showed an
acquired expression of CD44, both in Bowman space and in the
tubulo-interstitial space, in particular in periglomerular areas.
Using a combined immunohistochemical and histochemical
staining for CD44 and periodic acid–Schiff (PAS), respectively
(similar to the staining displayed in Figure 1e and f), we
detected that all glomeruli with early and advanced prolifera-
tive lesions in Bowman space were positive for CD44 (data not
shown). Within the glomerulus, CD44 co-localized with the
PECmarkers SSeCKS (Figure 5a) and claudin-1 (Figure 5b) but
not with the podocyte marker synaptopodin (Figure 5a).
Saline-treated WT mice did not reveal a glomerular CD44
staining nor claudin-1 staining in the glomerular tuft (data not
shown). As expected, NTS-injected cd44–/– mice did not
display renal CD44 expression, and fewer SSeCKS and claudin-
1 positive lesions were observed (Figure 5a and b). Next, we
evaluated whether the CD44-positive PEC population was the
primary origin of the proliferating PEC population. To this
end, we performed a triple staining for CD44, SSeCKS, and
Ki67 (Figure 5c). We found that most (78% 7%) of the Ki67-
positive PECs were CD44-positive as well.Kidney International (2018) -, -–-Although our data suggest that the differences in glomer-
ular cell proliferation between NTS-injected WT and cd44–/–
mice may be explained by a reduced presence of activated
PECs in cd44–/– mice, another explanation could be differ-
ences in glomerular influx of inflammatory cells. However,
counting the number of granulocytes, macrophages, and
CD8- and CD4-positive T cells revealed no significant dif-
ferences between NTS-injected WT and cd44–/– mice
(Figure 6a–d). A representative result for macrophage staining
in WT and cd44–/– mice is depicted in Figure 6e. A separate
count of the number of macrophages in the periglomerular
space revealed a difference between WT and cd44–/– mice—
the latter displayed fewer macrophages (Figure 6f).
CD44 deficiency reduces proteinuria and glomerular cell
proliferation in collapsing FSGS
To validate our findings obtained in experimental crescentic
glomerulonephritis, we employed the anti-Thy1.1 model for
collapsing FSGS, in WT Thy1.1 transgenic (tg) mice and
Thy1.1 tg cd44–/– mice. Anti-Thy1.1 injection in Thy1.1 tg
mice normally induces proteinuria within 1 hour, and typical5
Figure 5 | Fewer parietal epithelial cells (PECs) in crescentic lesions in cluster of differentiation 44–deficient (cd44–/–) mice. To detect
the presence of PECs in crescentic lesions, immunostaining was performed for the PEC markers SSeCKS (a) and claudin-1 (b). Wild-type (WT)
nephrotoxic serum (NTS)–injected mice showed an acquired expression of CD44 in SSeCKs (arrows, a) and claudin-1–positive PECs (arrows and
inset, b), which was not present in the cd44–/– mice (a, arrowheads). NTS-injected cd44–/– mice showed no acquired CD44 expression and less
SSeCKS- and claudin-1–positive lesions (arrowheads, a and b, respectively). Also, no colocalization was seen between SSeCKS or CD44 and the
podocyte marker synaptopodin (a). Triple immunofluorescence staining for Ki67, CD44, and SSeCKS (c). Nuclei are stained with 4’,6-diamidino-2-
phenylindole (blue). Using these three markers, we were able to establish the percentage of Ki67-positive cells present in PECs (SSeCKS positive)
and in activated PECs (CD44- and SSeCKS-positive; arrow). Bar ¼ 50 mm. To optimize viewing of this image, please see the online version of this
article at www.kidney-international.org.
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Figure 6 | No differences in the glomerular influx of inflammatory cells. Number of granulocytes, macrophages, and cluster of
differentiation (CD)8- and CD4-positive T cells in wild-type (WT) and CD44-deficient (cd44–/–) mice (a–d). Double staining for CD68 and agrin
was performed to analyze the macrophage influx on the renal cryosections of WT and cd44–/–mice (e,f). Periglomerular macrophage influx was
scored semiquantitatively based on CD68-positive staining on a scale of 0 to 5 (f). The number of positive cells per 50 glomeruli is represented
as mean  SEM, for WT and cd44–/– mice (n ¼ 5). *P < 0.05. Bar ¼ 50 mm. A.U., arbitrary unit. To optimize viewing of this image, please see the
online version of this article at www.kidney-international.org.
J Eymael et al.: CD44 drives PECs in crescentic glomerulonephritis and FSGS bas i c re sea r chsclerotic lesions develop within 7 days.4 After 8 days, we
analyzed the renal expression of CD44, which revealed that
saline-injected Thy1.1 tg mice displayed no renal CD44
expression (data not shown), whereas anti-Thy1.1 mAb-
injected Thy1.1 tg mice, but not Thy-1.1 tg cd44–/– mice,
acquired glomerular, periglomerular, and tubular CD44Kidney International (2018) -, -–-expression (Figure 7a, b). We found that, as in the NTS
model, 100% of the lesions detected in the PAS staining were
positive for CD44 (Figure 7a).
The urinary albumin:creatinine ratio of Thy1.1 tg cd44–/–
mice was 2-fold lower, compared with WT Thy1.1 tg mice
(Figure 7c). Renal function did not differ between WT Thy1.17
Figure 7 | Cluster of differentiation (CD)44 deficiency reduces proteinuria and the number of cells in extracapillary lesions in the Thy1.1
transgenic (tg) collapsing focal and segmental glomerulosclerosis model. Immunostaining for CD44 on a periodic acid–Schiff (PAS)–
stained section of a Thy-1.1 tg (a) and a Thy-1.1 tg CD44-deficient (cd44–/–) mouse (b), respectively. Only in the wild-type (WT) mouse
immunostaining was CD44 detected in the epithelial cells of affected glomeruli (arrow), tubuli (arrowhead), and periglomerular areas (asterisks).
Proteinuria expressed as mg albumin/mg creatinine ratio in Thy1.1 tg and Thy1.1 tg cd44–/– mice on day 8 after anti-Thy1.1 mAb injection (c).
Formation of collapsing lesions in the glomeruli was determined by an analysis of at least 50 glomeruli per mouse and expressed as the
percentage of affected glomeruli in Thy1.1 tg and Thy1.1 tg cd44–/– mice (d). Assessment of the number of nuclei in extracapillary lesions in
Thy1.1 tg and Thy1.1 tg cd44–/–mice (e). Data are given as mean  SEM for Thy1.1 tg (n ¼ 8) and Thy1.1 tg cd44–/– (n ¼ 7) mice. Mann-Whitney
U test (2-tailed); *P < 0.05; ***P < 0.001. Representative images of PAS-stained sections of Thy1.1 tg (f) and Thy1.1 tg cd44–/– mice (g).
Hyperplasia or multilayered accumulation of cells forming (pseudo)-crescents (f,g, arrows). Bar ¼ 50 mm. To optimize viewing of this image,
please see the online version of this article at www.kidney-international.org.
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Figure 8 | Cluster differentiation (CD)44 deficiency reduces glomerular cell proliferation in the Thy1.1 transgenic (tg) collapsing focal
and segmental glomerulosclerosis model. Total numbers of Ki67-positive cells located in the glomerular tuft (a) and Bowman space (b) were
counted per 50 glomeruli of Thy1.1 transgenic (tg) and Thy1.1 tg cd44–/– mice on 3,3’-diaminobenzidine–stained formalin-fixed paraffin
sections. Data are given as mean  SEM for Thy1.1 tg (n ¼ 8) and Thy1.1 tg cd44–/– mice (n ¼ 7). Mann-Whitney U test (2-tailed); *P < 0.05;
**P < 0.01. Representative images showing Ki67-positive cells 8 days after anti-Thy1.1 injection in Thy1.1 tg (c,e) and Thy1.1 tg cd44–/– mice
(d,f). Marked proliferation was detected in the glomeruli (asterisks, c,d) in both the glomerular tuft (arrowheads, e,f) and Bowman space
(arrows, e,f). Bar ¼ 100 mm (c,d). Bar ¼ 50 mm (e,f). To optimize viewing of this image, please see the online version of this article at www.
kidney-international.org.
J Eymael et al.: CD44 drives PECs in crescentic glomerulonephritis and FSGS bas i c re sea r chtg and Thy1.1 tg cd44–/– mice, with respective blood urea ni-
trogen values of 18.5 1.8 mmol/L versus 16.1 2.1 mmol/L.
Despite the differences in albuminuria, analysis of renal
histology revealed no significant difference in the percentage
of affected glomeruli, in a comparison of anti-Thy1.1-injected
WT Thy1.1 tg and Thy1.1 tg cd44–/– mice (Figure 7d). BothKidney International (2018) -, -–-WT Thy1.1 tg and Thy1.1 tg cd44–/– mice displayed the
typical lesions we normally observe in the anti-Thy1.1 model
(Figure 7f and g), with collapse of the glomerular tuft and
marked hyperplasia in Bowman space. However, quantitative
assessment of the number of nuclei within the extracapillary
cellular lesions revealed a reduced number of cells in the9
Figure 9 | Fewer parietal epithelial cells (PECs) in collapsing focal and segmental glomerulosclerosis lesions in cluster of differentiation
44–deficient (cd44–/–) mice. To detect the presence of PECs in collapsing lesions, immunostaining was performed for the PEC marker SSeCKS.
Thy1.1 transgenic (tg) mice injected with anti-Thy-1.1 mAb showed an acquired expression of CD44 in SSeCKS-positive PECs (arrows). In
contrast, Thy1.1 tg cd44–/– mice did not show acquired CD44 expression in SSeCKS-positive lesions (arrowheads). No colocalization was seen
between SSeCKS or CD44 with the podocyte marker synaptopodin. Bar ¼ 50 mm. To optimize viewing of this image, please see the online
version of this article at www.kidney-international.org.
bas i c re sea r ch J Eymael et al.: CD44 drives PECs in crescentic glomerulonephritis and FSGSlesion of the Thy-1.1tg cd44–/– mice, compared with the WT
Thy1.1 tg mice (Figure 7e).
In accordance with the results just described, the number
of Ki67-positive cells in Bowman space was significantly lower
in Thy1.1 tg cd44–/–mice compared with WT Thy1.1 tg mice.
A similar difference, to a lesser extent, was seen for the Ki67-
positive cells in the glomerular tuft (Figure 8a–f). As in the
NTS model, the extracapillary proliferative lesions were
positive for the PEC marker SSeCKS, which was less pro-
nounced in Thy1.1 tg cd44–/– mice (Figure 9). As in the NTS
model, triple staining for CD44, SSeCKS, and Ki67 revealed
that in the anti-Thy-1.1 model, the vast majority (92%  4%)
of the Ki67-positive PECs were CD44-positive as well.
CD44 deficiency reduces growth of PECs in culture
To examine the effects of CD44 deficiency on the behavior of
PECs, we performed a glomerular outgrowth assay as described
elsewhere.28 In this assay, we assessed the glomerular epithelial
outgrowth after culturing single isolated capsulated mouse
glomeruli. Capsulated glomeruli were isolated from the
cd44–/– and WTmice and cultured for 6 days, after which the
percentage of glomeruli with an outgrowth and the surface area
of the outgrowth was assessed for more than 500 glomeruli.
The percentage of glomeruli that formed an outgrowth was
reduced in the CD44-deficient glomeruli (Figure 10c–e). Also,
the surface area of the outgrowths was smaller in this group,
indicating that CD44 is directly involved in glomerular
epithelial cell growth (Figure 10f). In the WToutgrowths, the
cells were CD44-positive, unlike those from CD44-deficient
glomeruli (Figure 10g and h). By analyzing outgrowths at day
6, we were able to focus on the growth of the fast-growing10PECs, rather than podocytes that need at least 7 to 14 days to
form an outgrowth.29 This was further supported by the
finding that glomeruli without a capsule (n¼ 24) did not form
outgrowths at day 6 (Figure 10i). In addition, immunostaining
for PEC (SSeCKS, claudin-1) and podocyte (synaptopodin)
markers revealed homogenous staining of the outgrowth for
SSeCKS (Figure 10j–l) and claudin-1 but not for synaptopodin
(Supplementary Figure S2).
Collagen I and IV drive PEC migration in vitro in a
CD44-dependent manner
Matrix deposition is a key feature of lesion or crescent for-
mation. Collagen I normally is not expressed in the
glomerulus, but it is observed in various glomer-
ulopathies.30,31 In both models, we observed increased
cortical collagen I alpha 1 and IV mRNA expression, which
was about 2-fold less in CD44-deficient mice (data not
shown). In addition, PECs produce matrix within the scle-
rotic lesions and crescents. In earlier studies, we and others
showed that the matrix in the lesions resembled the matrix of
Bowman capsule, containing collagen IV alpha 1, 2, and 6.
Therefore, we postulated that collagen I and IV may be
involved in PEC migration. To test this in vitro, we employed
human PECs that expressed CD24, CD133, and CD44
(Supplementary Figure S3) in a haptotaxis assay. Notably,
established hPEC clones always express CD44, which may
suggest that these cultured hPECs have an activated pheno-
type. The haptotaxis assay revealed maximal migration of
hPECs towards collagen I and collagen IV at a coating con-
centration of 50 mg/ml (Figure 10a and b). Given that the
PECs expressed CD44, we evaluated the effect of neutralizingKidney International (2018) -, -–-
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icantly decreased migration of hPECs, whereas an isotype
control antibody had no effect (Figure 11a and b). As most of
the Ki67-positive PECs in vivo were CD44-positive, we
postulated that CD44 is important for cell activity and pro-
liferation. To test this in vitro, we performed a cell metabolic
activity assay (MTT assay) and evaluated the effect of
neutralizing CD44 with anti-CD44. However, neutralizing
CD44 did not produce a significant effect (P ¼ 0.07) on cell
activity (Figure 11c).
CD44 deficiency does not affect Erk1/2, YAP, and STAT3
signaling in PECs during experimental crescentic
glomerulonephritis and collapsing focal segmental
glomerulosclerosis
In the previous section, we showed in vitro that collagen I and
IV drive PEC movement in a CD44-dependent manner,
whereas CD44 neutralization tended to affect PEC prolifera-
tion as well (P ¼ 0.07). To gain further mechanistic insight
into the role of CD44 in vivo, we analyzed different signaling
pathways in WT and cd44–/– kidneys of the NTS and anti-
Thy1.1 model. Although numerous downstream signaling
pathways and factors that link to CD44 have been described,
we choose to limit our analysis to 3 candidates: phospho-
Erk1/2 (p-Erk1/2), Yes-associated protein (YAP), the
effector of the Hippo pathway, as well as phospho-signal
transducer and activator of transcription 3 (p-STAT3).
Notably, the aforementioned factors are part of signaling
pathways that all have been linked to CD44 and regulation of
cell migration and/or proliferation.32–34 We observed in both
the NTS and anti-Thy1.1 model an increased immunostain-
ing for p-Erk1/2 (Supplementary Figure S4A and B) and YAP
in the CD44-positive PECs (Supplementary Figure S5A and
B). Notably, the overall staining for p-Erk1/2 and YAP
appeared less pronounced in CD44-deficient mice compared
with WT mice. However, also in CD44-deficient mice, we
observed an increased immunostaining of p-Erk1/2 and YAP
in PECs in glomerular lesions, which suggests that the
expression of these signaling molecules is not (solely)
dependent on CD44. Finally, for both the NTS and anti-
Thy1.1 model, we did not observe expression of p-STAT3
expression in CD44-positive PECs (Supplementary
Figure S5C), which suggests that CD44 and pSTAT3
signaling are not linked to proliferating PECs.
DISCUSSION
Normally, CD44 is not expressed in the glomerulus, and studies
in animals and humans have shown that CD44 can be
considered to be a specificmarker of activated PECs that invade
the glomerular tuft during scarring glomerular dis-
eases.4,10,11,19 Our main research question was whether
acquired glomerular CD44 expression can be considered a
contributing factor in scarring glomerular diseases. Our results
reveal that CD44 deficiency changes the outcome of experi-
mental crescentic glomerulonephritis and collapsing FSGS. In
both models, we observed that CD44 deficiency results in lessKidney International (2018) -, -–-glomerular cell proliferation and reduced albuminuria. These
findings are in line with those of a recent study performed
independently in a different podocyte injury mouse model.
That study also found that CD44-deficient mice had a better
outcome, with reduced albuminuria and PEC proliferation.35
For crescentic glomerulonephritis, the number of histologi-
cally affected glomeruli was significantly reduced in the absence
of CD44. Even though the number of histologically affected
glomeruli was not different in the collapsing FSGS model, a
striking difference was found in the number of cells within the
extracapillary proliferative lesions. Although, we considered
both models to be valid for studying the role of CD44 in
scarring glomerular disease,4 they are different in regard to
pathogenesis, which could explain the difference seen in his-
tologic outcome relating to CD44 deficiency.
In experimental crescentic glomerulonephritis, fixation of
injected antibody to the GBM leads to complement activa-
tion, infiltration of polymorphonuclear neutrophils and
macrophages, and crescent formation.36–39 The cellular cres-
cents formed during crescentic glomerulonephritis are mainly
comprised of activated PECs,12 macrophages,40 and podo-
cytes.41 Notably, CD44 is expressed by both activated PECs
and macrophages under pathologic conditions, and macro-
phage depletion has been shown to be beneficial in crescentic
glomerulonephritis.42 Macrophages produce cytokines and
pro-fibrotic factors, such as tumor necrosis factor–a, trans-
forming growth factor–b, platelet-derived growth factor,
interleukin-1, and fibroblast growth factor–2, and thereby
contribute to the formation of crescents.43 However, our data
show that CD44 deficiency in crescentic glomerulonephritis
leads to a reduced presence of PECs in Bowman space,
whereas the number of glomerular macrophages was not
significantly affected. These observations indicate a link
among CD44-expressing activated PECs, the formation of
crescents, and the development of albuminuria. However, we
use a conventional cd44 knock-out mouse model, so alter-
native explanations for the reduction in albuminuria due to
the global CD44 deficiency are possible. We cannot exclude
the possibility that the reduced pathology and PEC hyper-
plasia within the glomerulus in cd44–/– deficient mice may be
driven (in part) by other cell types and processes not evalu-
ated in this study. Furthermore, our aim was to analyze the
effect of CD44 on crescent formation, so we did not evaluate
earlier time points, which could have revealed that CD44
deficiency resulted in less glomerular influx of poly-
morphonuclear neutrophils, and thereby less glomerular
damage and albuminuria.39,44,45 On the other hand, the
in vitro studies performed on WT and CD44-deficient
glomeruli did reveal a direct relationship between CD44
and growth of PECs, as the formation of outgrowths, con-
sisting of PECs, was reduced in cd44–/– glomeruli, compared
with WT glomeruli.
The anti-Thy1.1 model for collapsing FSGS is induced by
hitting podocytes with anti-Thy1.1 antibody, which results in
podocyte injury and activation of PECs. The subsequent
formation of adhesions between the glomerular capillary tuft11
Figure 10 | Cluster of differentiation (CD)44 deficiency reduces growth of parietal epithelial cells (PECs) in culture. Capsulated glomeruli
were isolated from CD44-deficient (cd44–/–) mice and wild-type (WT) control mice. Single capsulated glomeruli were isolated in a 24-well plate
(a) and cultured for 6 days. Cellular outgrowths were analyzed at day 6. Cellular outgrowth was impaired by CD44 KO (b,c,d). (Phase contrast
image [a–d]). The percentage of glomeruli forming outgrowths was significantly lower for CD44-deficient mice (e). The surface (continued)
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Figure 11 | Cluster of differentiation (CD)44 inhibition reduced collagen I– and IV– induced migration. Haptotactic migration under the
influence of various concentrations of collagen I (a), collagen IV (b), and CD44-neutralizing antibodies. CD133þ/CD24þ/CD44þ cells were
allowed to migrate under the influence of collagen I or collagen IV coatings to the underside of the transwell insert (10–100 ug/ml). For
neutralization, cells were pre-incubated for 30 minutes with anti-CD44 antibodies or isotype controls. Fold change was calculated over bovine
serum albumin (BSA)–coated controls. Data are given as mean  SEM (n ¼ 3). ***P < 0.001; **P < 0.01, for BSA versus collagen I or collagen IV.
The cell activity of CD133þ/CD24þ/CD44þ cells was measured using an MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide)
tetrazolium assay. The cells were nontreated or pre-incubated for 24 hours with anti-CD44 antibodies or isotype control (c). coll, collagen; ns,
nonsignificant; OD, optical density.
J Eymael et al.: CD44 drives PECs in crescentic glomerulonephritis and FSGS bas i c re sea r chand Bowman capsule provides an entry site for activated
PECs.10,19 Activated PECs contribute to deposition of extra-
cellular matrix material, which ultimately results in segmental
and global glomerulosclerosis. We observed that the number
of glomerular proliferating cells is reduced in the absence of=
Figure 10 | (continued) areas of the outgrowths of the cd44–/– glomeruli
WT mice (f). Data are given as mean  SD (n ¼ 4). **P < 0.01. The outg
CD44 staining also was observed surrounding the glomerulus (g, asteris
mice (h). Decapsulated glomeruli (n ¼ 24) did not form outgrowths at day
PEC marker SSeCKS in both the WT (j,k) and cd44–/– mice (l). Bars ¼ 400
zoom (k,l). DAPI, 4’,6-diamidino-2-phenylindole. To optimize viewing of t
international.org.
Kidney International (2018) -, -–-CD44, which most likely can be explained by a reduction in
proliferating PECs, because the anti-Thy1.1 model is not
characterized by massive glomerular influx of immune cells.
Despite a reduced number of proliferating glomerular cells
and reduced albuminuria, the absence of CD44 did not resultwere significantly smaller compared with the areas measured from the
rowths of the WT glomeruli showed a strong expression of CD44 (g).
k). CD44 immunostaining was not detected in cells from the cd44–/–
6 (i). The outgrowths showed a homogenous immunostaining for the
mm (a,j); 1000 mm (b–d); 200 mm (i); and 100 mm (g,h,k,l). Inserts: x2
his image, please see the online version of this article at www.kidney-
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point. One possible explanation could be that we have eval-
uated the kidneys too early, as persistently higher proteinuria
may lead to further progression of the glomerular injury and
induce additional lesions.46 We have no direct explanation for
the fact that the degree of albuminuria is not related to overall
histology in collapsing FSGS. Apparently, the number of
glomerular proliferating cells is a more sensitive parameter
that can be related to albuminuria rather than to histology in
the 2 tested models of glomerular scarring, as was suggested
recently for proliferating cells in the urine of FSGS patients.47
The number of glomerular proliferating cells also was
related to cortical collagen I expression in both models.
Notably, collagen IV is the type of collagen expressed in both
normal and diseased glomeruli (sclerosis), whereas collagen I
is normally not expressed in the glomerulus, but several
studies have shown glomerular collagen I expression in
various glomerulopathies.48–50 We found an increased
collagen I expression in both models tested. We reasoned that
the extracellular matrix delivers signals to activated PECs, so
we tested the migratory capacity of CD44 expressing human
PECs towards collagen I and collagen IV in vitro and indeed
found migration of PECs in a CD44-dependent manner,
whereas neutralization of CD44 tended (P ¼ 0.07) to reduce
PEC cell activity/proliferation in vitro as well. CD44 is known
to be involved in many cellular processes, including cell
migration and proliferation.51 In addition, many downstream
signaling pathways and factors have been linked to CD44 and
cell migration/proliferation, such as phospho-Erk1/2 (p-Erk1/
2), Yes-associated protein (YAP), the effector of the Hippo
pathway, and phospho-signal transducer and activator of
transcription 3 (p-STAT3). Although p-Erk1/2 and YAP were
upregulated in the hyperplastic lesions, analysis of these
signaling molecules did not reveal a clear difference between
WT and cd44–/– mice in our NTS and anti-Thy1.1 model,
which suggests that along with CD44-mediated signaling,
other pathways are operative. A recent study found that Erk1/
2 induce CD44 expression in PECs, leading to a pro-sclerotic
and migratory PEC phenotype.35 Another complicating factor
is that CD44 has many splice variants, which each have spe-
cific binding partners, thereby linking to various signaling
pathways. Elucidation of the exact molecular mechanisms
underlying proliferation of CD44-positive PECS during
experimental crescentic glomerulonephritis and collapsing
FSGS, as well as the CD44-mediated haptotactic response of
human PECs toward collagen I and collagen IV requires
substantial additional research.
Acquired glomerular CD44 expression by activated PECs is
required for the pathogenesis of experimental crescentic
glomerulonephritis and collapsing FSGS.METHODS
Animals and animal experiments
Wild type (WT), CD44-deficient (cd44–/–), Thy1.1 transgenic
(Thy1.1 tg), and cd44–/– Thy1.1 tg mice were all on a C57Bl/6
background. The genotype and phenotype of these mice have been14described previously, whereas the cd44–/– Thy1.1 tg mice were ob-
tained by cross-breeding cd44–/– mice with Thy1.1 tg mice in the
current study.44,52 All animal experiments were approved by the
Animal Ethics Committee of the Radboud University Nijmegen and
conducted in accordance with the European Communities Council
Directive (86/609/EEC).
Crescentic glomerulonephritis was induced as described previ-
ously.53 Briefly, 7-week-old WT and cd44–/– mice were injected
i.p. with 4 mg nephrotoxic serum (NTS) supplemented with 80 mg
CpG Oligo (tebu-bio, Heerhugowaard, The Netherlands).
Urine was collected at day 13 in metabolic cages, for 18 hours.
Mice were sacrificed at day 14, and kidneys and blood were collected.
Collapsing FSGS was induced as described previously.52 Briefly, 7-
week-old Thy1.1 tg and Thy1.1 tg cd44–/– mice were injected
i.v. with 1 mg anti-Thy1.1 monoclonal antibody. Urine was collected
at day 7 in metabolic cages, for 18 hours. Mice were sacrificed at day
8, and kidneys and blood were collected.
Albumin in urine was measured by radial immunodiffusion
(Mancini), and urinary creatinine and plasma ureum concentrations
were determined in the clinical diagnostic facility of Radboudumc.
Renal histology
Renal paraffin sections (4 mm) were deparaffinized, dehydrated, and
stained with PAS stain. Fifty glomeruli per mouse were evaluated
for hypertrophy, hyperplasia, sclerosis, adhesions, or hyalinosis,
which were expressed as a percentage of affected glomeruli.
Evaluation of histology was performed on blinded sections by 2
nephropathologists.
Proliferating cells were immunostained for the Ki67 proliferation
marker, as described later (immunohistochemistry staining), and
positive nuclei were counted in 50 glomeruli per mouse on blinded
sections. To assess CD44 expression in relation to the histology, a
CD44 immunostaining was combined with a PAS staining.
Glomerular histology and the presence of CD44 was evaluated in all
glomeruli present in the section.
Immunohistochemistry staining
Immunohistochemistry was performed on 4-mm paraffin. CD44
immunostainings were combined with a PAS staining. Sections were
blocked with Avidin/Biotin Blocking Kit (Vector Laboratories, Bur-
lingame, CA) and 3%H2O2. The sections were subjected tomicrowave
antigen retrieval in citrate buffer with pH 6, followed by incubation
with the primary (Table 1) and secondary antibodies. For secondary
antibodies, we used biotinylated goat anti-rabbit (Ki67) or goat anti-
rat (CD44) (Vector Laboratories). Detection was carried out with
Vectastain ABC Kit (Vector Laboratories), with peroxidase used as a
label, and 3,30-diaminobenzidine used as a substrate. Subsequent to
the CD44 immunostaining, PAS staining was performed.
Immunofluorescence staining
Immunofluorescence staining was performed on renal cryosections
(2 mm) or formalin-fixed paraffin sections (4 mm) as described
previously.39 The primary antibodies used are listed in Table 1.
Appropriate Alexa conjugated antibodies (Invitrogen Life Technol-
ogies, Breda, The Netherlands) were used for detection. Stained
sections were post-fixed with 1% paraformaldehyde–phosphate
buffer saline and embedded in VectaShield mounting medium
H-1000 (Brunschwig Chemie, Amsterdam, The Netherlands).
Staining intensities were scored semi-quantitatively for 50 glomeruli
per mouse, by 2 researchers, using a fluorescent microscope (Leica
Microsystems, GmbH, Germany). The number of granulocytes,Kidney International (2018) -, -–-
Table 1 | Primary antibodies used
Antibody Manufacturer
Anti-agrin (MI91) Laboratory collection54
Anti-C3c (FITC labeled) Nordic, Tilburg, The Netherlands
Anti-CD4 BD Biosciences, Alphen aan de Rijn,
The Netherlands
Anti-CD8a BD Biosciences, Alphen aan de Rijn,
The Netherlands
Anti-CD24 Santa Cruz Biotechnology,
Santa Cruz, CA
Anti-CD44 BD Biosciences, Alphen aan de Rijn,
The Netherlands
Anti-CD68 Serotec, Oxford, United Kingdom
Anti-CD133 Miltenyi Biotec GmbH, Bergisch Gladbach,
Germany
Anti-claudin1 Abcam, Cambridge, United Kingdom
Anti-fibrinogen (FITC
labeled)
Nordic, Tilburg, The Netherlands
Anti-Ly-6G (FITC labeled) BD Biosciences, Alphen aan de Rijn,
The Netherlands
Anti-SSeCKS Origene, Rockville, MD
Anti-synaptopodin Santa Cruz Biotechnology, Santa Cruz, CA
Anti-Ki67 (clone sp6) Thermo Scientific, Breda, The Netherlands
Anti-phospho-STAT3 Cell Signaling Technology, Leiden, The
Netherlands
Anti-phospho-Erk1/2 Cell Signaling Technology, Leiden, The
Netherlands
Anti-YAP Cell Signaling Technology, Leiden, The
Netherlands
CD, cluster of differentiation; FITC, fluorescein isothiocyanate.
J Eymael et al.: CD44 drives PECs in crescentic glomerulonephritis and FSGS bas i c re sea r chmacrophages, CD4- and CD8a-positive T cells was counted in 50
glomeruli per mouse.
Triple immunofluorescence staining for Ki67, CD44, and SSeCKS
on paraffin sections needed a different protocol, as 2 of the primary
antibodies (anti-Ki67 and anti-SSeCKS) were rabbit polyclonal anti-
bodies. To circumvent cross-reaction between both markers, we
stained Ki67 using the Alexa Fluor 488 Tyramide SuperBoost Kit,
(ThermoFisher Scientific, Waltham, MA). After the tyramide-based
fluorescence staining, we performed another heat-induced antigen
retrieval in citrate buffer with pH 6, for 15 minutes, to remove the
bound antibodies. Subsequently, normal immunofluorescence stain-
ing was performed for CD44 and SSeCKS. All Ki67- and SSeCKS-
positive cells were evaluated to determine whether they also
expressed CD44.
Cell culture and flow cytometry
Human PECs (hPECs), in particular CD24 andCD133 double positive
cells, were isolated and cultured essentially as described previously.9
Briefly, glomeruli were isolated from healthy kidney tissue using
gradual sieving. Glomeruli were seeded in endothelial cell growth
medium EGM-2MV (Lonza, Breda, The Netherlands), with 20% fetal
bovine serum. Cellular outgrowth was harvested and re-seeded. Iso-
lated clones obtained by limiting dilutions were characterized for
expression of CD24, CD133, and CD44 using the antibodies listed in
Table 1. Immunofluorescence was analyzed on a FC500 Flow Cy-
tometer (Beckman Coulter, Woerden, the Netherlands). One of the
isolated clones (3011) was used for in vitro experiments.
Glomerular outgrowth assay
Untreated, healthy WTmice (n ¼ 4) and cd44–/– (n ¼ 4) mice were
sacrificed. Both male and female mice were used. Kidneys were
isolated and minced, using 2 scalpels, and then pressed through a
300-mm sieve. The kidney homogenate then was rinsed throughKidney International (2018) -, -–-a 75-mm sieve and subsequently a 53-mm sieve, using Hanks’ Balanced
Salt Solution (HBSS) (ThermoFisher Scientific). The kidney struc-
tures (glomeruli and tubuli) present on both sieves were collected in
Dulbecco’s Modified Eagle’s Medium (ThermoFisher Scientific,
Waltham, MA), supplemented with 20% fetal calf serum (FCS), and
transferred into Ultra-Low Attachment Microplates (Corning
Costart, Fisher Scientific, Landsmeer, the Netherlands). Single
capsulated and decapsulated glomeruli were collected with a pipette
under an inverted light microscope and transferred into 24-well
plates. Glomeruli were cultured for 6 days at 37 C, 5% CO2, in
endothelial basal medium (EBM #CC-3121, Lonza,) supplemented
with EGM-MV Single Quots kit (Lonza), and an additional 5% fetal
bovine serum (Lonza) and 1% Pen/Strep. After 6 days, microscopic
images were made using light microscopy (EVOS fl microscope,
ThermoFisher Scientific), and the percentage of outgrowing
glomeruli was determined. In addition, the surface area in mm2 of
glomerular outgrowth was assessed using ImageJ. A total of 523 single
glomeruli (248 from WT and 275 from cd44–/– mice) were isolated
and evaluated. In addition, the outgrowth assay was performed on
24 decapsulated glomeruli. (12 WT and 12 cd44–/– glomeruli).
To characterize the outgrowing cells, immunofluorescence
staining was performed on outgrowing glomeruli at t ¼ 6 days. For
this process, the medium was carefully removed, and glomeruli were
washed twice with phosphate buffer saline and fixated for 10 minutes
at room temperature using 2% paraformaldehyde þ 4% sucrose in
phosphate buffer saline, after which cells were washed twice. The
cells were stained with primary antibody for SSeCKS, CD44, claudin-
1, and synaptopodin and subsequently stained with the secondary
antibodies—anti rabbit IgG (HþL) Alexa 568 (ThermoFisher Sci-
entific), anti goat IgG (HþL) Alexa 568, or anti rat IgG (HþL) Alexa
647 (ThermoFisher Scientific). For mounting, DAPI-Fluoromount G
(Southern Biotech, Birmingham, AL) was used.
In vitro migration and cell viability assay
Migration of hPECs was studied in transwell cell culture inserts with
an 8-mm pore size (Thermo Scientific, Breda, The Netherlands).
Inserts were coated at the bottom with indicated concentrations of
collagen I, collagen IV, or 2% bovine serum albumin (all Sigma-
Aldrich Chemie, Nürnberg, Germany). Serum (EGM-2 MV
[Lonza] 0.5% FCS)-starved hPECs were seeded (105 cells) in the
upper chambers. Where indicated, cells were pre-incubated with
anti-CD44 antibody or isotype control. Medium containing 0.5%
FCS was added into the lower chambers. After 5 hours, at 37 C,
migrated cells at the bottom side of the inserts were quantified with
0.2% crystal violet. Dye was extracted using 10% glacial acetic acid,
and the optical density was measured at 590 nm.
Cell metabolic activity was measured using the MTT assay. Cells
grown in EGM-2 MV medium (Lonza), with 20% FCS, were incu-
bated with the CD44 neutralizing antibody or an isotype control
antibody for 24 hours prior to the MTT assay.
Cells were incubated in the presence of MTT reagent
containing tetrazolium MTT (3-(4, 5-dimethylthiazolyl-2)-2,
5-diphenyltetrazolium bromide (Sigma-Aldrich, St Louis, MO) for 2
to 4 hours, until purple precipitate was visible. The dye was extracted
using a detergent reagent, and the optical density was measured at
570 nm.
Statistical Analysis
Results are expressed as mean, SEM or SD. Groups were
compared using a paired t-test or Mann-Whitney U test. P values
of <0.05 were considered statistically significant.15
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Figure S1. Histology of wild type (WT)and cluster of differentiation
44–deficient (cd44 –/–) mice. Representative images of periodic acid–
Schiff (PAS)–stained sections of nontreated WT control (A) and
cd44–/– mice (B). Both the WT and cd44–/– mice showed a normal
histology. Bar ¼ 50 mm.
Figure S2. Parietal epithelial cells (PECs) form glomerular outgrowths.
Immunostaining for the tight junction molecule claudin-1 (PECs) and
the podocyte-specific cytoskeletal protein synaptopodin showed
marked immunostaining for claudin-1 within the cell junctions in the
glomerular outgrowths. Claudin-1–positive cell junctions were seen in
more confluent outgrowths that were obtained with glomeruli from
wild type mice. Synaptopodin staining was restricted to the podo-
cytes of the glomerulus (arrow). Outgrowing cells were negative.
Bar ¼ 100 mm. DAPI, 4’,6-diamidino-2-phenylindole.
Figure S3. Isolation of human primary parietal epithelial cells (hPECs).
Human parietal epithelial cells (hPECs) from glomerular outgrowths
were characterized by flow cytometry for cluster of differentiation
(CD)24 and CD133. The gated (“target cells”) were also positive for
CD44 as well as claudin-1 (data not shown).
Figure S4. Cluster of differentiation (CD)44 deficiency does not affect
Erk1/2, Yes-associated protein (YAP), or STAT3 signaling in parietal
epithelial cells (PECs) during experimental crescentic glomerulone-
phritis and collapsing focal segmental glomerulosclerosis. Phospho-
Erk and CD44 double immunostaining on wild-type (WT) and CD44-
deficient (cd44–/–) kidney sections treated with nephrotoxic serum.
p-ERK was detected in tubular structures and glomeruli. In CD44-
negative glomeruli, the PECs were negative or showed a weak
staining for p-Erk. A strong increase in expression was detected in
CD44-positive PECs (WT, arrows). In cd44–/– mice, a lower number of
glomeruli showed immunostaining for p-Erk. However, in some
glomeruli, clear staining was seen in PECs in lesions or on Bowman
capsule (cd44–/–, arrow; A). The same staining was performed on
kidneys sections of anti-Thy-1.1 injected Thy-1.1 transgenic (tg) and
Thy-1.1 tg cd44–/– mice. Strong staining for p-Erk was detected in the
CD44-positive PECs in glomerular lesions (Thy-1.1 tg, arrow). In Thy-1.1
tg cd44–/– mice, fewer glomeruli showed immunostaining for p-Erk.
However, in these mice p-Erk also could be detected in some
glomeruli in PECs within lesions (Thy-1.1 tg cd44–/–, arrow; B).
Bar ¼ 50 mm.
Figure S5. Cluster of differentiation (CD)44 deficiency does not affect
Yes-associated protein (YAP) signaling in parietal epithelial cells
(PECs) during experimental crescentic glomerulonephritis and
collapsing focal segmental glomerulosclerosis. YAP and CD44 double
immunostaining on wild type (WT) and CD44-deficient (cd44–/–)
kidney sections treated with nephrotoxic serum (NTS). YAP was
detected in tubular structures and glomeruli. In CD44- negative
glomeruli, the PECs were negative or showed a weak staining for YAP.
A strong increase in expression was detected in CD44-positive PECs
(WT, arrows). In cd44–/– mice, fewer glomeruli showed immuno-
staining for YAP in PECs. However, as for p-Erk, in some glomeruli,
clear staining still was seen in PECs (cd44–/–, arrow; A). The same
staining was performed on kidneys sections of anti-Thy-1.1 injected16Thy-1.1 transgenic (tg) and Thy-1.1 tg cd44–/– mice. An overall strong
increase in immunostaining of both tubuli and glomeruli could be
noted, and marked staining for YAP was detected in the CD44-
positive PECs in glomerular lesions (Thy-1.1 tg; arrow). In Thy-1.1 tg
cd44–/– mice, less YAP immunostaining was detected in tubular and
glomerular cells. However, also in this model, YAP was detected in
some glomeruli in PECs within lesions of cd44–/– mice (Thy-1.1 tg
cd44–/–; arrow; B). Pphospho-STAT3 and CD44 double immuno-
staining on WT kidney sections of the NTS model (C) and the anti-
Thy-1.1 model (D). Phospho-STAT3 was detected in tubular cells and
cells in the interstitium (C, D, arrowheads) but not in glomeruli or
CD44-positive PECs (C, D, arrows). Bar ¼ 50 mm.
Supplementary material is linked to the online version of the paper at
www.kidney-international.org.
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